Delivery Order SPE2DB24D2101-SPE2DB25FKPSS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count) valued at $2,535.30, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Brilinta 60 mg tablets (quantity 60 count) valued at $1,664.52. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is due for completion by September 16, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Brilinta 90 mg tablets (60-count units) at a ceiling value of $4,019.96. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The order is scheduled for completion by August 28, 2025, with the place of performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,329.04. This non-set-aside delivery order represents the continuation of pharmaceutical supply services to support federal medical procurement needs, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.27 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (100 unit dose packages) on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract ceiling value of $1,741.14. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance—is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,941.37 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger pharmaceutical...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPSSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,556.35 on September 18, 2025, for the supply of Brilinta 90 mg tablets (60-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025, performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. This delivery order falls under AmerisourceBergen Drug Corp's $1 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal vendor for military and veteran healthcare systems, supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities. The parent IDC enables the company to fulfill diverse pharmaceutical support needs across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/18/25 |